126.56
price down icon0.58%   -0.62
 
loading
前日終値:
$127.18
開ける:
$126.97
24時間の取引高:
2.47M
Relative Volume:
0.43
時価総額:
$220.22B
収益:
$43.84B
当期純損益:
$13.94B
株価収益率:
15.82
EPS:
7.9979
ネットキャッシュフロー:
$6.78B
1週間 パフォーマンス:
-0.86%
1か月 パフォーマンス:
-5.32%
6か月 パフォーマンス:
-2.38%
1年 パフォーマンス:
+10.85%
1日の値動き範囲:
Value
$126.44
$128.45
1週間の範囲:
Value
$125.00
$128.94
52週間の値動き範囲:
Value
$110.86
$140.84

Abbott Laboratories Stock (ABT) Company Profile

Name
名前
Abbott Laboratories
Name
セクター
Healthcare (1144)
Name
電話
(224) 667-6100
Name
住所
100 ABBOTT PARK ROAD, ABBOTT PARK, IL
Name
職員
114,000
Name
Twitter
@AbbottNews
Name
次回の収益日
2025-10-15
Name
最新のSEC提出書
Name
ABT's Discussions on Twitter

ABT を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Medical Devices icon
ABT
Abbott Laboratories
126.53 221.35B 43.84B 13.94B 6.78B 7.9979
Medical Devices icon
BSX
Boston Scientific Corp
101.43 151.78B 19.35B 2.78B 3.49B 1.8696
Medical Devices icon
SYK
Stryker Corp
377.28 146.70B 23.82B 2.92B 4.02B 7.5574
Medical Devices icon
MDT
Medtronic Plc
93.49 120.73B 34.20B 4.69B 5.30B 3.6218
Medical Devices icon
EW
Edwards Lifesciences Corp
82.03 47.45B 5.69B 1.41B 577.90M 6.9828

Abbott Laboratories Stock (ABT) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2025-10-10 開始されました The Benchmark Company Buy
2025-07-18 アップグレード Jefferies Hold → Buy
2025-06-16 開始されました Leerink Partners Market Perform
2024-10-08 開始されました Oppenheimer Outperform
2024-09-19 開始されました Piper Sandler Overweight
2024-07-30 ダウングレード Edward Jones Buy → Hold
2024-05-30 開始されました Goldman Buy
2023-07-21 アップグレード Wolfe Research Underperform → Peer Perform
2023-05-30 ダウングレード Morgan Stanley Overweight → Equal-Weight
2023-04-20 繰り返されました Barclays Overweight
2023-04-20 繰り返されました Bernstein Outperform
2023-04-20 繰り返されました JP Morgan Overweight
2023-04-20 繰り返されました Raymond James Outperform
2023-04-20 繰り返されました UBS Buy
2023-04-20 繰り返されました Wolfe Research Underperform
2023-03-29 開始されました UBS Buy
2022-10-26 開始されました Mizuho Neutral
2022-10-18 開始されました Barclays Overweight
2022-10-12 開始されました Jefferies Hold
2022-07-06 開始されました Wolfe Research Underperform
2022-03-02 再開されました BofA Securities Buy
2022-01-27 繰り返されました Credit Suisse Outperform
2022-01-27 繰り返されました Morgan Stanley Overweight
2022-01-27 繰り返されました Raymond James Outperform
2022-01-27 繰り返されました UBS Buy
2021-12-10 開始されました RBC Capital Mkts Outperform
2021-10-27 アップグレード Atlantic Equities Neutral → Overweight
2021-10-14 開始されました Redburn Neutral
2021-05-25 開始されました Barclays Overweight
2021-04-15 開始されました Atlantic Equities Neutral
2021-01-28 アップグレード BTIG Research Neutral → Buy
2020-09-11 開始されました Wolfe Research Outperform
2020-06-01 ダウングレード Goldman Neutral → Sell
2020-03-05 開始されました Citigroup Buy
2020-02-13 開始されました Goldman Neutral
2020-02-06 再開されました BTIG Research Neutral
2020-01-02 ダウングレード Guggenheim Buy → Neutral
2019-06-13 繰り返されました BofA/Merrill Buy
2019-02-07 繰り返されました BofA/Merrill Buy
2019-01-02 ダウングレード Citigroup Neutral → Sell
2018-11-30 アップグレード Goldman Neutral → Buy
2018-10-16 開始されました Barclays Overweight
2018-06-27 開始されました Bernstein Outperform
2018-01-30 繰り返されました Citigroup Neutral
2018-01-25 繰り返されました Stifel Buy
2018-01-25 アップグレード William Blair Mkt Perform → Outperform
2018-01-03 開始されました Evercore ISI Outperform
2018-01-02 アップグレード JP Morgan Neutral → Overweight
2018-01-02 アップグレード Morgan Stanley Equal-Weight → Overweight
2017-10-19 繰り返されました RBC Capital Mkts Outperform
2017-10-19 繰り返されました Stifel Buy
すべてを表示

Abbott Laboratories (ABT) 最新ニュース

pulisher
08:59 AM

Data supports Abbott Tendyne mitral valve replacement - MassDevice

08:59 AM
pulisher
06:26 AM

Billionaire Israel "Izzy" Englander Has Loaded Up on This Dividend King. Should You? - The Motley Fool

06:26 AM
pulisher
12:38 PM

Technical signs of recovery in Abbott LaboratoriesMarket Volume Summary & Target Return Focused Stock Picks - newser.com

12:38 PM
pulisher
Oct 27, 2025

Abbott’s New Study on Dydrogesterone: A Potential Game-Changer for Endometriosis Pain - TipRanks

Oct 27, 2025
pulisher
Oct 27, 2025

Is Abbott Laboratories (Common Stock) (ABL0) stock a buy for dividend portfoliosJuly 2025 Price Swings & Precise Buy Zone Identification - Fundação Cultural do Pará

Oct 27, 2025
pulisher
Oct 27, 2025

Abbott Laboratories wins Illinois court case on NEC baby formula claims - Global Food Industry News

Oct 27, 2025
pulisher
Oct 27, 2025

Using R and stats models for Abbott Laboratories forecastingWeekly Market Summary & Real-Time Volume Triggers - newser.com

Oct 27, 2025
pulisher
Oct 27, 2025

What is the fair value estimate for Abbott Laboratories (ABL) stock in 2025Trade Risk Report & Smart Swing Trading Techniques - newser.com

Oct 27, 2025
pulisher
Oct 27, 2025

Will a bounce in Abbott Laboratories offer an exitSwing Trade & High Conviction Investment Ideas - newser.com

Oct 27, 2025
pulisher
Oct 26, 2025

Will Abbott Laboratories (ABL) stock maintain strong growthStop Loss & Verified Momentum Stock Watchlist - newser.com

Oct 26, 2025
pulisher
Oct 25, 2025

Is Abbott Laboratories stock a buy in volatile markets2025 Risk Factors & Growth Focused Investment Plans - newser.com

Oct 25, 2025
pulisher
Oct 24, 2025

Abbott Laboratories wins lawsuit over safety of baby formula - Chicago Tribune

Oct 24, 2025
pulisher
Oct 24, 2025

Abbott Wins Third Bellwether as Judge Rules Human-Milk Alternative ‘Unfeasible’ - USA Herald

Oct 24, 2025
pulisher
Oct 24, 2025

Abbott Wins Third Bellwether In Cow Milk Baby Formula MDL - Law360

Oct 24, 2025
pulisher
Oct 24, 2025

Abbott wins third of four 'bellwether' infant formula lawsuits - Crain's Chicago Business

Oct 24, 2025
pulisher
Oct 24, 2025

Protein Bar Market Size, Share, and Growth 2025-2035 | Abbott - openPR.com

Oct 24, 2025
pulisher
Oct 24, 2025

Abbott Can't Expand Glucose Monitor Sales Ban At UPC - Law360

Oct 24, 2025
pulisher
Oct 24, 2025

Abbott Laboratories (ABT): Exploring Valuation After a Recent Share Price Pullback - Yahoo Finance

Oct 24, 2025
pulisher
Oct 24, 2025

Meet RFK’s Corporate Underlings - The American Prospect

Oct 24, 2025
pulisher
Oct 23, 2025

Is Abbott Laboratories stock dividend growth reliableJuly 2025 Catalysts & Smart Swing Trading Alerts - newser.com

Oct 23, 2025
pulisher
Oct 23, 2025

How Abbott’s Innovative Partnerships Are Shaping Its 2025 Valuation Amid 12.8% YTD Gain - simplywall.st

Oct 23, 2025
pulisher
Oct 23, 2025

United States Chronic Obstructive Pulmonary Disease Market Report 2025-2033, Profiles of AstraZeneca, Pfizer, GSK, Novartis, Astellas Pharma, Abbott Laboratories, Boehringer Ingelheim, Almirall - GlobeNewswire

Oct 23, 2025
pulisher
Oct 23, 2025

1 Safe-and-Steady Stock with Exciting Potential and 2 We Question - The Globe and Mail

Oct 23, 2025
pulisher
Oct 22, 2025

Synlait Milk Confirms Investment Regulator's Approval for Abbott's Acquisition of North Island Assets - MarketScreener

Oct 22, 2025
pulisher
Oct 22, 2025

A Look Into Abbott Laboratories Inc's Price Over Earnings - Sahm

Oct 22, 2025
pulisher
Oct 22, 2025

Here is What to Know Beyond Why Abbott Laboratories (ABT) is a Trending Stock - Yahoo Finance

Oct 22, 2025
pulisher
Oct 22, 2025

The 5 Most Interesting Analyst Questions From Abbott Laboratories’s Q3 Earnings Call - Yahoo Finance

Oct 22, 2025
pulisher
Oct 21, 2025

How Abbott Laboratories stock compares to growth peersMarket Movement Recap & Free Weekly Watchlist of Top Performers - newser.com

Oct 21, 2025
pulisher
Oct 21, 2025

Can Abbott Laboratories (Common Stock) (ABL0) stock sustain margin levelsGap Down & Entry and Exit Point Strategies - newser.com

Oct 21, 2025
pulisher
Oct 21, 2025

Is Abbott Laboratories (ABL) stock cheap by valuation metricsTake Profit & Risk Adjusted Buy/Sell Alerts - newser.com

Oct 21, 2025
pulisher
Oct 21, 2025

Is Abbott Laboratories showing signs of accumulationMarket Movement Recap & Expert Approved Momentum Ideas - newser.com

Oct 21, 2025
pulisher
Oct 21, 2025

Volatility clustering patterns for Abbott LaboratoriesPortfolio Risk Report & Real-Time Market Trend Scan - newser.com

Oct 21, 2025
pulisher
Oct 21, 2025

Walmart to sell Abbott's CGM in US 1st - Fierce Biotech

Oct 21, 2025
pulisher
Oct 21, 2025

Abbott - Boston Athletic Association

Oct 21, 2025
pulisher
Oct 21, 2025

Daiwa Securities Adjusts Abbott Laboratories Price Target to $136 From $134, Maintains Outperform Rating - MarketScreener

Oct 21, 2025
pulisher
Oct 21, 2025

Walmart to be first US retailer to sell Abbott's continuous glucose monitor - Reuters

Oct 21, 2025
pulisher
Oct 21, 2025

Walmart (WMT) Expands Health Offerings with Abbott's Lingo Gluco - GuruFocus

Oct 21, 2025
pulisher
Oct 21, 2025

Functional Foods Forecast and Company Analysis Report 2025: A $678.32 Billion Market by 2033 Featuring Abbott, Amway, BASF, Cargill, Clif Ba, Danone, General Mills, Kellogg, Kerry, Nestle - Yahoo Finance

Oct 21, 2025
pulisher
Oct 21, 2025

Walmart said to become first physical retailer to sell Abbott’s OTC glucose monitor, Lingo - Seeking Alpha

Oct 21, 2025
pulisher
Oct 21, 2025

Walmart to be first US retailer to sell Abbott's continuous glucose monitor, Axios reports - TradingView

Oct 21, 2025
pulisher
Oct 21, 2025

How to read the order book for Abbott Laboratories2025 Earnings Surprises & Trade Opportunity Analysis Reports - newser.com

Oct 21, 2025
pulisher
Oct 21, 2025

Abbott Laboratories (ABT) Rated Buy as Benchmark Highlights Diagnostics Growth and Global Resilience - Insider Monkey

Oct 21, 2025
pulisher
Oct 21, 2025

Bringing Biomarkers to the Bedside: The Clinical Promise of Abbott’s TBI Test - NeurologyLive

Oct 21, 2025
pulisher
Oct 21, 2025

Did Mixed Segment Results and Narrowed Guidance Just Shift Abbott Laboratories' (ABT) Investment Narrative? - Yahoo Finance

Oct 21, 2025
pulisher
Oct 20, 2025

Boston Scientific (BSX) Reports Q3: Everything You Need To Know Ahead Of Earnings - TradingView

Oct 20, 2025
pulisher
Oct 20, 2025

Will Abbott Laboratories price bounce be sustainableTrade Entry Report & Step-by-Step Swing Trade Plans - newser.com

Oct 20, 2025
pulisher
Oct 20, 2025

Why analysts recommend Abbott Laboratories (ABL) stockPortfolio Return Summary & AI Powered Trade Plan Recommendations - newser.com

Oct 20, 2025
pulisher
Oct 20, 2025

Is Abbott Laboratories (ABL) stock a safe buy pre earningsTrade Exit Report & Weekly Top Gainers Trade List - Trung tâm Dự báo KTTV quốc gia

Oct 20, 2025
pulisher
Oct 20, 2025

Lobbying Update: $1,128,989 of ABBOTT LABORATORIES lobbying was just disclosed - Quiver Quantitative

Oct 20, 2025
pulisher
Oct 20, 2025

Why pension funds invest in Abbott Laboratories (Common Stock) (ABL0) stockQuarterly Trade Report & Fast Exit and Entry Strategy Plans - Trung tâm Dự báo KTTV quốc gia

Oct 20, 2025
pulisher
Oct 20, 2025

Abbott Q3 Earnings Review: Tariff, Diagnostics Cap Near-Term Gains - The Globe and Mail

Oct 20, 2025

Abbott Laboratories (ABT) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
medical_devices BSX
$101.43
price down icon 1.03%
medical_devices SYK
$377.24
price down icon 1.68%
medical_devices MDT
$93.41
price down icon 0.73%
medical_devices EW
$82.03
price up icon 1.61%
$79.10
price up icon 0.97%
大文字化:     |  ボリューム (24 時間):